TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,183
|
1,155 | |
| Financial expenses |
0
|
1 | |
| Earnings before taxes |
200
|
368 | |
| EBITDA |
191
|
343 | |
| Total assets |
1,761
|
1,805 | |
| Current assets |
1,249
|
1,518 | |
| Current liabilities |
204
|
65 | |
| Equity capital |
1,437
|
1,631 | |
| - share capital |
50
|
50 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.6%
|
90.4% | |
| Turnover per employee |
1,183
|
1,155 | |
| Profit as a percentage of turnover |
16.9%
|
31.9% | |
| Return on assets (ROA) |
11.4%
|
20.4% | |
| Current ratio |
612.3%
|
2335.4% | |
| Return on equity (ROE) |
13.9%
|
22.6% | |
| Change turnover |
28
|
11 | |
| Change turnover % |
22%
|
2%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.